Cargando…
Differences in serum cytokine levels distinguish between clinically noninvasive lung adenocarcinoma and invasive lung adenocarcinoma: A cross‐sectional study
BACKGROUND: Lung cancer incidence and mortality remain high and are now the leading cause of cancer‐related death. Lung adenocarcinoma (LUAD) is one of the main histological subtypes of lung cancer. Previous studies have shown the role of inflammation in the development of lung cancer, but the relat...
Autores principales: | Zeng, Bingjie, Wang, Xianzhao, Qin, Yueyang, Cao, Leiqun, Zhang, Congcong, Meng, Fanyu, Chen, Changqiang, Wang, Jiayi, Ma, Lifang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486205/ https://www.ncbi.nlm.nih.gov/pubmed/37692791 http://dx.doi.org/10.1002/hsr2.1522 |
Ejemplares similares
-
Integrated Clinical and Prognostic Analysis of the m(6)A RNA Methylation Regulator YTHDF3 in Pan-Cancer and its Correlation with Cancer Cell Proliferation
por: Cao, Leiqun, et al.
Publicado: (2022) -
Transcriptional Repression of Ferritin Light Chain Increases Ferroptosis Sensitivity in Lung Adenocarcinoma
por: Wang, Yikun, et al.
Publicado: (2021) -
ISGylation of EMD promotes its interaction with PDHA to inhibit aerobic oxidation in lung adenocarcinoma
por: Zhang, Congcong, et al.
Publicado: (2022) -
YAP 5-methylcytosine modification increases its mRNA stability and promotes the transcription of exosome secretion-related genes in lung adenocarcinoma
por: Yu, Wenjun, et al.
Publicado: (2022) -
Evolution of lung adenocarcinoma from preneoplasia to invasive adenocarcinoma
por: Zhu, Jianfei, et al.
Publicado: (2022)